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A bioprinting printing approach to regenerate cartilage for microtia treatment
Abstract
The need to search for biomaterials that can promote tissue regeneration and easy to replicate and
manufacture is a major driving force for research and development in the area of reconstructive surgery
and regenerative medicine. It is of great importance to otolaryngologists to find alternate solutions that
require harvesting large amounts of autologous cartilage in patients needing cartilage grafts. Due to its
very limited self-regeneration capacity, cartilage repair and reconstruction is extremely challenging.
Microtia is a congenital condition of abnormal development of the outer and/ or the middle ear and can
range from mild to complete absence of the ear. Current treatment methods such as autologous,
alloplastic and prosthetic reconstruction have limitations such as donor site morbidity, long-term
complications and implant failure. 3D printing is an exciting solution to address the challenges of microtia
and create customised implants. The ability to deposit cells and biomaterials in a controlled and precise
manner, allows the fabrication of implants with complex internal architecture and functional properties
not achievable through traditional manufacturing methods. Despite the ability to mimic native properties
and structure of tissue, 3D printed constructs using pristine inks lack the structural integrity and adequate
mechanical properties for use in vivo or handling. These requirements highlight the importance of ink
development and selection, which is a continuing challenge in the bioprinting process. This review will
address the current treatment options for patients with microtia and the potential of 3D bioprinting in area
of auricular cartilage regeneration. In particular, the use of hybrid printing to better mimic the practical
and functional requirements of an ear scaffold will be discussed.
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Abstract
The need to search for biomaterials that can promote tissue regeneration and easy to replicate
and manufacture is a major driving force for research and development in the area of
reconstructive surgery and regenerative medicine. It is of great importance to otolaryngologists
to find alternate solutions that require harvesting large amounts of autologous cartilage in
patients needing cartilage grafts. Due to its very limited self-regeneration capacity, cartilage
repair and reconstruction is extremely challenging. Microtia is a congenital condition of
abnormal development of the outer and/ or the middle ear and can range from mild to complete
absence of the ear. Current treatment methods such as autologous, alloplastic and prosthetic
reconstruction have limitations such as donor site morbidity, long-term complications and
implant failure. 3D printing is an exciting solution to address the challenges of microtia and
create customised implants. The ability to deposit cells and biomaterials in a controlled and
precise manner, allows the fabrication of implants with complex internal architecture and

functional properties not achievable through traditional manufacturing methods. Despite the
ability to mimic native properties and structure of tissue, 3D printed constructs using pristine
inks lack the structural integrity and adequate mechanical properties for use in vivo or handling.
These requirements highlight the importance of ink development and selection, which is a
continuing challenge in the bioprinting process. This review will address the current treatment
options for patients with microtia and the potential of 3D bioprinting in area of auricular
cartilage regeneration. In particular, the use of hybrid printing to better mimic the practical and
functional requirements of an ear scaffold will be discussed.
Keywords: 3D bioprinting, cartilage regeneration, microtia, bioink development

1. Introduction
In Otorhinolaryngology, cartilage is of particular interest because of its presence in multiple
structures in the ear (pinna), nose (septum and alar) and throat (larynx and trachea). Further it
is used as graft material in surgical interventions from cerebrospinal fluid (CSF) leak repairs
[1], Ossicular Chain Reconstruction (OCRs) [2], Microtia reconstruction [3] and
Laryngotracheal reconstructions [4]. It is therefore a tissue of great importance to
Otolaryngologists. Due to its very limited self-regeneration capacity, cartilage repair and
reconstruction is extremely challenging.
Microtia is a congenital condition where there is an abnormal development of the outer and/ or
the middle ear and can range from mild to complete absence of the ear [5]. Overall, the
incidence of microtia is about 1-4 per 10,000 births, but can vary between countries. Of these,
10% of patients will present with bilateral diseases [6]. Treatment is demanding with long hours
and numerous stages of surgery. In addition, complications present in the donor site and the
receiver site includes failure, scarring, and most of all, donor site morbidity.
Bioprinting is an exciting solution to address the challenges of microtia and create customised
implants, but research in this area around the world has not yet translated into meaningful
results of clinical relevance. In this review, the various treatment options for microtia will be
discussed and the potential of 3D bioprinting in the area of cartilage regeneration will be
highlighted. In particular, the use of 3D printing to satisfy the mechanical, biological and
printing requirement of the entire construct will be discussed. The range of printable
biomaterials and cell sources relevant to auricular reconstruction will also be reviewed.

2.

Pathology

Ear deformity can have a significant social and psychological impact on the individual. It can
occur as a result of trauma (67,000 patients have ear deformities caused by burns/year in the
US), burns, cancer (malignant lesion of the ear account for approximately 13% of all head and
neck melanomas), scars, or congenital abnormalities [7].

The external ear consists of the auricle and the external ear canal. Microtia is a developmental
malformation of the external ear, characterised by a small abnormally shaped auricle or pinna.
The disorder can be either a genetic or environmental factor, an isolated condition or part of a
spectrum of abnormalities. Several possibilities for the cause is suggested but still poorly
understood. These include vertebrae abnormalities [8], medications [9, 10], genetic disorders
[11], and even illness during pregnancy [12]. There are two forms of microtia, unilateral or
bilateral. Unilateral occurs in 79-93% of the cases and the right side is more often affected [6,
13]. In individuals that have unilateral microtia, the speech and language developments are
normal, due to the normal functioning collateral ear. Figure 1 presents different grades of
microtia, ranging from mild structural abnormalities to complete loss of the ear. The
classification system was first developed by Hermann Marx in 1926 and was later modified by
Meurman [5]. Grade I refers to individuals having all features of the normal auricle, but the
pinna is smaller than normal. In grade II, only some features are present. Grade III is most
commonly seen in patients that undergo ear reconstruction as only a portion of soft tissue is
present, resulting in a peanut-shaped ear. In grade IV (or anotia), there is no external ear and
auditory canal. This is often associated with hearing loss and requires treatment for hearing
impairment and surgical ear reconstruction. Another classification also in use separates
microtic ear deformities into lobular and conchal types [3, 11].

I
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III

Condral

Lobular
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Figure 1 Ear classified by grades I to IV and as lobular or conchal types

3.

Treatment options for microtia

3.1

Autologous reconstruction

Autologous reconstruction remains the first treatment option for patients with classical microtia
and no prior surgery, as this approach leaves options open for allografts or Osseo integrated
prosthesis if it fails. The reconstruction of microtia can be broken down into 2 main steps. First
is to mimic the contours of the normal ear by “sculpturing” a framework from autogenous
cartilage. The second step is the coverage of the framework with skin grafts or adjacent skin
[3]. It has been suggested that reconstruction of the ear can begin as early as 5 to 6 years of age
to prevent social and psychological stress from peers at school. Many have reported the benefits
of delaying the surgery until 9 to 10 years old [14-17] , and when the chest circumference has
grown to at least 60cm so that there is sufficient cartilage for harvesting [5]. The benefits of
autologous reconstruction include long-term stability, limited rejection and minimises the risk
of extrusion of the implant. The grafts also possess the potential to grow with the patient as
they mature [18].

3.1.1 Techniques
The anatomy of the ear consists of eminences and depressions, shown in Figure 2. A significant
breakthrough in the field of ear reconstruction was introduced by Tanzer in the late 1950s [19].
It involves a 4-stage reconstruction process from carving a solid block of autogenous costal
cartilage. Costal cartilage (rib cartilage) has proven to be the source of cartilage that provided
an adequate quantity and integrity [20, 21]. Modifications of this technique are still regarded
as the 'gold standard' for patients with microtia and other ear deformities [22]. Brent mastered
a three-stage reconstruction building from this technique, while Nagata and Firmin further
refined the technique to allow early positioning of the lobular segment of the vestige and
constructing in 2 stages [14, 17]. A summary of the different techniques to reconstruct microtia
is shown in Table 1, all aiming to further improve aesthetics and decrease complication rates
[23].

Concha

Triangular fossa
Cymba conchae

Depression
Helix

Tragus

Antihelix

Intertragic incisure
Antitragus

External auditory meatus

Lobule

Figure 2 Illustration of the ear anatomy

Table 1.Summary of techniques to reconstruct microtia
Surgeon

Ages

Stages

Tanzer [19, 24]

6-7+

4

Technique
I.
II.
III.
IV.

Brent[21]

6-8+

3

I.
II.
III.
IV.

Nagata [14-16, 25, 26]

10+

2

I.

II.
Park [27]

10+

3

I.
II.

III.

Firmin [17]

9-10+

2

I.
II.

Rotation of Lobule
Fabrication of the costal cartilage
framework
Elevation of the framework
Construction of tragus and conchal
cavity
Fabrication of the costal cartilage
framework
Lobule transposition
Elevation of framework
Tragus reconstruction
Fabrication of the costal cartilage
framework. Include tragus, conchal
cavity and lobule
Elevation of the framework after 4
months. Covered with skin graft
Insertion of tissue expander.
Continues for 5 months
Fabrication of costal cartilage
framework and inserted between
skin flaps
Skin incisions to create tragus,
conchal and external auditory
canal
Framework placed under skin
pocket for 6 months
Sulcus created using additional
cartilage graft for projection

3.1.2 Limitations of autologous reconstruction
Donor site morbidity is a constant concern reported in several case studies because of the need
to harvest multiple sections of the costal rib, mainly 6th, 7th and 8th, to make just the auricular
body framework and 9th for the helical component [28]. Besides pain, there is also a potential
for lung collapse or chest wall depression. As the costal ribs are harvested, the stability of the
anterior ends of the rib against the sternum is much less and the rib bends inwards through
growth and negative respiratory pressure [29]. This is some of the reasons why several studies
prefer Brent’s technique over Nagata’s as it requires less cartilage, but also delaying the surgery
till the patient is much older [23, 30].

A method to prevent chest wall deformity include using cartilage from cadavers (allogeneic
reconstruction). The use of cadaver cartilage has also shown to be a promising alternative to
autologous cartilage. Studies conducted by Go et al. [31] on 42 patients demonstrated that
patients having their empty perichondrial space filled with irradiated cadaver cartilage after
harvesting are equally effective in preventing chest wall depression as ones filled with
autologous cartilage. Another study used irradiated homograft costal cartilage directly to
perform auricular reconstruction on 19 patients. The reports showed no short-term and longterm complications after 36 months and 90% of subjects were satisfied with the outcome [32].
Limitations for using cadaver cartilage is most certainly the possibility of graft infection and
surgical cost [31]. Nevertheless, this approach can eliminate the need for graft harvesting,
hence donor site morbidity.

Aesthetically, some of the limitations include cartilage resorption and scarring. Costal cartilage
is still reported as the best substitute for auricular reconstruction [20, 21]. However, the costal
cartilage has no elastic fibres and lacks the flexibility of a normal ear, giving it an overall rigid
appearance [28, 33]. There are also reports on calcification in using costal cartilages for
auricular reconstruction [34]. Finally, it also resorbs rapidly and as the skin contracts heavily
during the healing process, scarring and skin necrosis can occur. Table 2 summarises the types
of complications after costal cartilage rib harvesting and are usually indicators of success and
failure in auricular reconstructive surgery [20] .

Table 2. Percentage of complications after autologous auricular reconstruction
Complications

Incidence

Total number of
patients in study

Reference

Infection

5 (19%)

27

[11]

Chest deformities

5 (6%)

88

[35]

3(7%)

42

[36]

Thoracic scoliosis

4(25%)

16

[29]

Cartilage Resorption

3 (11%)

27

[11]

Pleural Tear

1 (4%)

27

[11]

19 (22%)

88

[35]

1 (4%)

27

[11]

1 (0.3%)

350

[37]

1 (7%)

15

[3]

7 (8%)

88

[35]

Under/oversized
framework

3 (11%)

27

[11]

Scarring

3 (20%)

15

[3]

12 (14%)

88

[35]

21 (6%)

350

[37]

2 (5%)

40

[3]

4 (1.2%)

350

[37]

Donor-site morbidity

Necrosis

Atelectasis

Aesthetics

Exposure

3.2 Alloplastic reconstruction
Alloplastic reconstruction can offer several advantages over autologous reconstruction, such
as avoiding donor site morbidity, shorter surgery time, improved size and contour matching,

and less demanding learning curve for the surgeon. The ideal shaped ear can be produced in
advance and several materials such as nylon mesh, silicone, polyethylene, acrylic and polyester
have been introduced over the years as potential candidates [20, 38]. As with all other foreign
body implants, there are potential risks associated with this method, such as infection, necrosis
and implant exposure. Another difficulty in manufacturing alloplastic implants is to
accommodate all the variations in size and shape required to mimic the patient’s normal ear.
The implants are not customised and often the surgeon would have to compromise for one that
is the closest match. This is not the case in autologous reconstruction where the surgeons can
carve the cartilage to obtain what is required. Interestingly, around 10% of patients still have
either a under or oversized framework, showing the complexity in shaping the harvested
cartilage and matching the contralateral ear either by eye or imaging technologies [11].
Silicone framework for auricular reconstruction was first introduced by Cronin in the 1960s
[39, 40] and later by Ohmori et al. [41, 42]. These materials showed good initial results, with
flexibility mimicking the native cartilage, excellent aesthetic outcomes and donor site
morbidity was not a concern. Follow up results however, found that implant exposure was a
real concern and minor trauma or abrasion can cause implant failure.
Polyethylene (PE) was first described for use as a framework in auricular reconstruction by
Berghaus in 1983[43]. It is a non-reactive material that is available in high-density porous
configurations with sizes of around 100-200µm. The porosity provides good anchorage for
tissues compared to the smooth silicone as described by Cronin, thus allowing vascular and
soft tissue in-growth [38]. The current commercially available implant, Medpor® (Porex
Surgical Inc, Stryker, GA), is a porous and flexible polyethylene framework pioneered by John
Reinisch that comes in two parts, a helical rim and an ear base, allowing better sizing and
positioning [44]. Despite improvements to operative techniques, the majority of complications
reported are still a result of framework protrusions and implant exposures rather than infection.
Reinisch et al [45] reported the largest series of reconstruction using PE framework on 786 ears
and reported an exposure rate of 7% with no major infection during a 12 year follow up. Other
studies with follow-ups up to 11 years have also reported implant exposure being the most
common issue [46, 47]. Long-term studies are still required to assess the implant performance
over a lifetime, but early results have allowed Medpor® to become the most favourable
alloplastic material for surgeons when performing a total ear reconstruction. Since Medpor®
is relatively infection resistant; exposures can be managed quite effectively through complete
flap coverage [48]. By not having to wait for cartilage to grow and mature, reconstruction can

be done before the child enters school [49]. In addition, ear reconstruction can performed at
the same time as canal atresia (absence of an ear canal) surgery allowing children to have
completely functional and aesthetically good looking ears as early as three to four years of age
[38].

3.3 Prosthetic reconstruction
Prosthetic reconstruction is a cost effective method to cover areas of defect for patients who
are unable or in need to postpone surgical reconstruction. Surgeons would usually consider an
auricular prosthesis in situations such as [44, 50]:
1) Traumatic loss of the auricle or surrounding tissue
2) Failed autologous reconstruction
3) Underlying medical conditions
4) Age
5) Following tumour resection with possibility of recurrence
6) Inability to undergo multiple surgeries
The alloplastic ear is generally made from silicone and created as a mirrored contralateral ear
through solution casting or more recently, additive manufacturing [51, 52]. There are various
methods of attaching an auricular prosthesis to the skin, by either adhesives or an osseointegrated approach [53-55]. With adhesives, no surgery is needed and there is lower possibility
of infections and inflammations around the skin. However, long-term contact with adhesives
may result in allergic contact dermatitis and are especially difficult for patients who have
limited vision to accurately put on. The latter approach allows the patient to accurately wear
the prosthesis without a mirror and can withstand larger mechanical load during activities [56].
The concept of osseo-integration as reported by Branemark in the 1960s could be considered
as one of the most significant advances in prosthetic surgery over the past 20 years [50, 57-59].
Using titanium screws as bone anchored fixtures, these implants can be connected to load
bearing prosthetics with high success rates [54, 55, 60, 61]. The bone implants are intended to
last a lifetime and prosthesis can be replaced every 2 to 5 years depending on wear [60].

4.

3D bioprinting

3D printing have become increasingly popular in reconstructive surgery as this technology
enables fabrication of patient-specific models for pre-operative planning, surgical guides,
education purposes or implants. Computed tomography (CT) and magnetic resonance imaging
(MRI) can be used to provide information regarding tissue geometries and the function at
cellular level of the tissue [62, 63]. These raw data are then converted into a computer-aided
design (CAD) model, which are often used as a stereolithography (STL) file. STL files can be
imported into the 3D printer by slicing them into thin horizontal 2D layers, containing exact
geometrical information of the 3D model. The slicing thickness of the layers and filament
spacing is referred to as the “resolution” of a printer and depends on the ink and the nozzle tip
of the syringe [62-64]. Finally, the accurate 3D-printed model is then built bottom-up layer by
layer from the 2D slices.
Bioprinting combines the technologies of 3D printing and molecular biology. It enables
geometrically precise scaffolds to be fabricated easily and to act as a platform for living cells
to grow and mature either in vitro or in vivo. Eventually the scaffold will degrade over time
leaving native functional tissue in the predetermined shape, arrangement and location.
Furthermore, the ability to control the delivery of “bioink” facilitates accurate and
homogeneous distribution of cells in the scaffold. This is particularly beneficial in fabricating
scaffolds for cartilage repair when the turnover of cartilage is very slow and nutrient transfer
relies heavily on diffusion. A study conducted by Leverson et al. [65, 66] noted that nonuniform distribution of cells led to overcrowding on the scaffold surface and that a thorough
distribution of cells within the structure plays a vital part in extracellular matrix (ECM)
production. The internal architecture could also be important in chondrogenesis and
vascularisation, which could be incorporated into the print design to induce specific biological
responses, such as vascular loops [67]. Tissue maturation and specific tissue matrix deposition
are also found to be related to matrix stiffness and porosity, both of which can be easily
controlled by printing parameters[68].

4.1 Types of Biofabrication techniques
There are two 3D bioprinting techniques widely adopted in scaffold fabrication for cartilage
regeneration: inkjet based printing and extrusion based printing systems (Figure 3). Inkjet

printing operates on either thermal or piezoelectric actuators, which produce pressure pulses to
form ink droplets (Figure 3a). The electrical heater uses air-pressure for the pulses to form
droplets from the nozzle tip [63]. Both techniques are non-contact processes and are well
known for the fast printing speed and high accuracy. Risk associated with fast printing speeds
and small diameter sized nozzles are tip clogging, preventing the use of high viscosity inks and
high cell densities in this method [62]

Figure 3 Bioprinting systems A) ink-jet based printing and; B) extrusion-based printing
techniques

Extrusion printers on the other hand deposit the ink into a continuous filament rather than micro
droplets by a pneumatic air-pressure or mechanical plunger based delivery system.

A

minimum filament diameter of ~100µm results in structures with lower resolution compared
to the above-mentioned techniques (Figure 3b). This fabrication technique however, is ideal
for high viscosity inks and allows the printing of cell-laden hydrogels carrying high cell-density
[62, 63, 69]. The advantage of extrusion-based printer towards cell viability after the printing
process is studied by Park et al.[69]. They were able to prove that cells encapsulated in the
hydrogel showed higher cell viability and attachment to the synthetic framework than cells
seeded onto the prefabricated framework[69].

4.2 Hybrid extrusion printing
Biofabrication of the ear cartilage for example, requires a scaffold that matches the shape of
the contralateral ear and is able to incorporate autologous chondrocytes or stem cells. It also
needs to be strong enough to withstand contractive forces of the skin and natural bending, as
well as degrading slowly for neo-cartilage formation. These requirements highlight the
importance of ink development and selection, a component most challenging in the bioprinting
process as it should satisfy both the biological needs of cell, but also the physical and
mechanical needs of the printing process itself [70]

Hybrid printing, which is the printing of constructs using one or more inks, has been explored
as a promising strategy for engineering tissue constructs where simply one type of bioink
cannot satisfy the mechanical, biological and printing requirement of the entire construct. The
core element of hybrid printing involves co-deposition of two or more elements in a spatial
controlled manner. For instance, one structure could be cell-free, providing structural integrity
and mechanical stability of the 3D printed construct, while the other being cell-laden, provides
the conductive environment enabling cell growth and differentiation. An example of a hybrid
printing process is where polycaprolactone (PCL) is used as a structural material and printed
in between chondrocyte-impregnated alginate strands [71]. In most instances, constructs with
complex shapes are in need of a sacrificial material to account for angulation and orientation.

The combination of a synthetic polymer as a framework and a cell-laden hydrogel enable the
possibility to fabricate cartilage-like tissues as a 3D printed construct. This method is a
promising alternative to single material inks for the reconstruction of the auricle and to produce
patient-specific, large-volume tissues [28, 69, 72-74]. The final 3D printed construct can be
divided into three main components as shown in Figure 4: 1) sacrificial material, 2) structural
framework, and 3) cell supporting material. Each component has specific requirements
necessary to build up a functional 3D construct and will be discussed in the following section.

Figure 4 Hybrid printing steps: A) Bioprinting a sacrificial material; B) addition of structural
support for mechanical integrity; C) printing cell supporting material on top or in between
strands; D) removal of sacrificial material to obtain final scaffold

4.2.1 Sacrificial materials
'Sacrificial materials' are required to achieve optimal shape fidelity and to improve the accuracy
of 3D printed constructs. Therefore, the most important requirement of this material is the
ability to be removed easily after the printing procedure. In addition, extra materials must be
printable under similar conditions to other materials and they should be biocompatible. Because
of these special properties, there are only a limited number of sacrificial materials available to
select from as listed in Table 3[62, 63].

Table 3: Overview of the printable sacrificial materials used for auricular cartilage
regeneration
Material

Scaffold design

Sacrificial procedure

Reference

Pluronic (F-127)

Ear shape

Sacrificed with water

[72]

PVA

Ear shape

Sacrificed with aqueous
solution

[75]

PEG

Ear shape

Sacrificed with distilled water
or cell culture media

[73, 74]

PVA= Poly (vinyl alcohol); PEG= Poly (ethylene-glycol)

Pluronics ® (Lutrol F127) are a class of commercially available thermosensitive hydrogels that
have been widely reported as delivery systems for drugs and proteins [76]. These triblock
copolymers of PEO-PPO-PEO (poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene
oxide)) can exhibit gel-like behaviour at concentrations between 15-30% w/w, and is a
reversible process that depends on physiological temperature, pH and the critical micellar
concentration (CMC) [77]. One major drawback is the rapid dissolution of Pluronics in aqueous
medium, thus limiting its use in long-term drug release or tissue encapsulation applications [78,
79]. This drawback in drug delivery however, is advantageous when considering it as a
sacrificial support material for bioprinting. Kang et al. [72], used Pluronic F-127 as sacrificial
support for the cell-laden hydrogel mixture to guarantee the printed ear shape prior to
crosslinking. Afterwards, the un-crosslinked Pluronic F-127 was easily washed out with
water[72].
Poly (vinyl alcohol) (PVA) is a water-soluble synthetic polymer with high swelling properties.
It can also be easily degraded by biological organisms through hydrolysis of its hydroxyl
groups on the carbon backbone [80]. The complete decomposition of PVA in water can be
achieved by immersing it in ~100°C for 30 minutes. Visser et al. [75], printed the anatomical
structure of the human ear based on PCL with PVA as a support. The PVA was easily sacrificed
through washing in hot water without compromising the quality of the target structure [75].

Poly(ethylene-glycol) (PEG) is a water soluble polyether that is non-immunogenic, non-toxic
and possess useful properties such as protein and cellular resistivity [81]. PEG was used as

sacrificial material to support the fabrication of ear scaffolds in the work conducted by Lee et
al. [73, 74]. PCL and PEG polymers were deposited layer-by-layer into a porous framework
and the PEG components were easily removed with distilled water or cell culture media once
printing was completed [73, 74].

4.2.2 Structural framework
To ensure the integrity of the scaffold after printing, polymers with sufficient mechanical
strength can be incorporated into the design, herein referred to as the “structural framework”.
When printed alongside other bio-inks, these materials can give rise to the overall rigidity of
the scaffold, thereby improving the ease of handling for surgeons during implantation and help
to maintain shape fidelity in post printing cleaning stages. In the case of hybrid printing, the
presence of a structural framework within a scaffold design can provide temporary support for
the weaker hydrogels and maintain their shape before crosslinking [82]. In the long run, this
framework also protects the cell laden hydrogels from external forces to give time for cells to
proliferate, differentiate and mature over time, such as skin contractions during healing in
auricular cartilage reconstruction[71, 72, 74].

A list of printable polymers used as structural frameworks in scaffolds for auricular cartilage
regeneration is listed in Table 4. Polylactic acid (PLA) is an organic biodegradable polyester,
which is biocompatible and immunologically inert. Additionally, PLA has a melting
temperature of 170 - 180 °C and is easy printable, making it interesting for 3D printing
methods[83].

Polycaprolactone is a Food and Drug Administration (FDA) approved bioresorbable polyester
and is used for medical advices since the 1980s [84]. It is one of the most commonly
investigated biocompatible polymers for 3D printing because of the low melting point of 60°C
and a slow degradation time (~1.5 to 2 years) [85, 86]. The low melting temperature enables
PCL to be printed easily and in hybrid printing- alongside cell-laden hydrogels [87]. In addition,
the synthetic polymer is well-known for excellent cell attachment, cell proliferation and a rapid
cooling after extrusion, which minimises cell damage from heat transfer and provides longterm structural stability [72, 88-91].

PCL framework as support for the mechanical strength of a scaffold is one of the most
commonly seen applications for 3D-printed biomaterials. Visser et al. [75], printed a uniform
PCL scaffold in the shape of an outer ear with an auger screw driven melt extruder. This
fabrication method showed promising results in the shape resolution of the print with overhangs
and pertinent human dimensions [75]. Many research groups support their hybrid scaffolds
with the synthetic material, which allows control of the mechanical properties and provides the
shape [69, 72]. An alternate approach to use PCL as structural support in a scaffold was to
design a cage-like structure surrounding the cell-laden hydrogel [82]. The cage was designed
to prevent the cell-laden hydrogel from in vitro scaffold contraction while the tissue matures.
This study showed that the framework maintains the shape during maturation and is a
promising technique to withstand contractions and deformations [82].

Table 4: Printable polymers as structural materials used for auricular cartilage scaffolds

Material

Scaffold
design

MW

Pattern
design#

Mechanical
testing

Mn45000;
Mw 48000–90000

d = 0.801.80 mm

-

-

d = 300 µm
f = 130 µm

References

PCL

Ear shape

PCL

Ear shape

PLA

Ear model and
components

Filament
(Builder Premium
3D Printer)

Slice
resolution
200 µm

PCL

Cylindrical
scaffold

(Polysciences,
Warrington, PA)

d = 1000 µm
f = 200 µm

Tensile tests:
Elastic modulus
tensile stress

[69]

Cylindrical cage

Medical grade
(Purasorb; Purac
Biomaterials)

-

Microindenter:
Young’s modulus

[82]

PCL

Bending tests:
ΔLoad%

-

PCL= Polycaprolactone; PLA= Polylactic acid; d = strand spacing; f = filament width

[75]

[72]

[92]

4.2.3 Cell supporting material
For the encapsulation of cells in a hydrogel, natural polymers (biopolymers) such as collagen,
gelatin, alginate or fibrin are generally more suitable than synthetic polymers (Table 5).
Hydrogels are known for their high-water retention, which protects the cells from drying during
the printing process. Biopolymers interact positively with cells and have high biocompatibility
but are limited by low stiffness and strength [93-95]. The hydrogel can provide the required
environment for the cells to maintain their migration, production of extracellular molecules and
proliferation[64].

Hyaluronic acid (HA) is a natural polymer often used for cartilage regeneration. HA is an
anionic, non-sulphated glycosaminoglycan (GAG) and is one of the main components of the
ECM in the body. It is well -known as a support material for cells to facilitate cell adhesion,
migration and proliferation [96, 97]. The weak mechanical properties and viscous nature
however, require HA to be blended with other hydrogels or chemically modified (attachment
of a methacrylate group) so that it can be photo-crosslinked to provide stability after printing
[98].

Collagens constitutes a family of proteins present in the ECM of connective tissues. It
comprises of three polypeptide chains that form a triple-helix structure and arranged in fibrils
found in tissues such as tendon, bone, cartilage and skin [99]. Type II collagen is the
predominant protein found in elastic cartilage with a small amount of type I collagen. Collagen
is easily degraded and resorbed by the body and allows good attachment to cells. However, its
mechanical properties are very low making it difficult to stack vertically when 3D printed and
the rapid resorption by the body can affect the scaffold stability and maturation [100].

Fibrin is a protein, which is part of the clotting process in blood. Fibrin hydrogels seeded with
chondrocytes can increase the production of GAG, which influences the production of ECM.
Kang et al. [72], used a mixture of fibrinogen, gelatin, HA and glycerol as chondrocytes-laden
hydrogel for auricular cartilage regeneration. Fibrinogen was cross-linked with thrombin,
which converts it to fibrin. The mixture of the hydrogel maintained the structure after printing
without cross-linking because of its high viscosity. Additionally, the hydrogel protected the
cells during the printing process and produced microchannels for nutrient diffusion after the

sacrificial procedure [72]. Limitations for fibrin includes degrading prematurely prior to adding
cell culture media.

Gelatin is an irreversibly hydrolysed form of collagen and mostly extracted from bones or skins
of animals. It is often used for 3D cell printing applications due to its similarity to the
extracellular matrix. The low stiffness of gelatin is a disadvantage for many applications;
however, it is possible to overcome these limitations with chemical modifications of the gelatin
hydrogels, as well as for biological properties [101]. GelMA is gelatin functionalized with
methacrylate groups, where the hydrogel can become chemically crosslinked through presence
of ultraviolent radiation [102]. Melchels et al. [103], printed the bioink consisting of 5% w/w
GelMA and equine chondrocytes and assessed their viability. The cell were unaffected by the
printing process, showing with an overall viability of 90% after 14 days.

Alginate is one of the most commonly used cell-laden hydrogels for 3D printed tissue
constructs. However, many studies have limited the study to chondrocyte, as alginate does not
have the necessary cell-adhesion motifs for cell-ECM interactions. Therefore, for adherent cell
types, alginates are commonly modified with RGD containing peptides to promote adhesion
and proliferation [104]. The anionic polysaccharide is commonly received from brown algae
and is well known as a supportive material for cells in cartilage tissues. An alginate
chondrocyte-laden hydrogel to repair cartilage defects of rabbit ear models was studied by Park
et al. [69]. The 3D printed scaffolds with the cell-laden alginate hydrogel showed complete
cartilage regeneration after 3 month of in vivo studies. In addition, the cell printed structures
were completely integrated into the surrounded native auricular cartilage of the rabbits and
formed round aggregates [69].

Lee and co-workers on the other hand, designed a large 3D printed ear construct using PCL as
a structural framework and two different cell-laden hydrogels [74]. The study printed alginate
encapsulated with human auricular chondrocytes, and porcine ear cartilage-derived
decellularised extracellular matrix (ear-cdECM) onto the pores of the framework. After 8
weeks, they were able to show that the cells underwent chondrogenesis and were not affected
by the long printing process with the hybrid printing approach [74]. The study by Kundu et al.
[105] went even further and used a synthetic framework with three different compositions of
the alginate hydrogel (I - alginate hydrogel without chondrocytes; II - alginate with
chondrocytes; and III - cell-laden hydrogel with TGF-β as a growth factor). The combination

of a cell-laden hydrogel with a growth factor showed promising results for applications in
auricular cartilage regeneration [105].
Table 1: Overview of the printable cell supporting materials used for auricular cartilage
regeneration

Material

Scaffold design

Cells

Printing
method

Reference

Fibrinogen

Ear shape

Rabbit Chondrocytes

Extrusion

[72]

Gelatin

Ear shape

Equine Chondrocytes

Extrusion

[103]

Alginate

Cylindrical
scaffold

Rabbit Chondrocytes

Extrusion

[69]

Nanocellulose –
Alginate

Ear shape

Human Chondrocytes

Extrusion

[106]

Alginate-ECM

Ear shape

Human chondrocytes

Extrusion

[74]

Alginate-TGFβ

Cubic scaffold

Human Chondrocytes

Extrusion

[105]

Fibrinogen Collagen

Cubic scaffold

Rabbit Chondrocytes

FibrinogenHyaluronic acid

Cylindrical
scaffold

Goat Mesenchymal Stem
cells

Extrusion

[82]

ChitosanHyaluronic acid

Nanofilms

Rabbit Mesenchymal Stem
cells

Inkjet

[108]

4.3

Inkjet

[107]

Cell sources

4.3.1 Primary Chondrocytes
Auricular cartilage is a type of elastic cartilage that is composed predominantly of ECM with
relatively few cells. The distinction between elastic cartilage and the other subtypes; hyaline
and fibrocartilage, is in the collagen, elastic fibre and tissue morphology [28].The tissue itself
has a very slow turnover at cellular and molecular level, so there is limited capacity for selfrenewal and repair. Considerable success has been accomplished in a bio-engineered ear

cartilage using isolated chondrocytes [33, 109, 110]. Primary chondrocytes isolated from
human or animal sources can be mixed within hydrogel matrices to create “bio-inks” suitable
for printing [105, 111]. One major drawback in obtaining the initial seeding density of primary
chondrocytes is that they can de-differentiate upon multiple expansions to fibroblast, thus are
unable to generate appropriate matrix the same way as normal cartilage. Furthermore, as a
consequence of the de-differentiation process, it switches from collagen type II synthesis to
collagen type I. Most studies do not recommend chondrocytes to be used after the third passage.
This leads to difficulty in expanding chondrocytes in vitro and limiting its use [112]. Acquiring
large amounts of human cartilage to expand and stimulate is also not practical, due to limitation
in availability and morbidity of donor sites in the body [7]. Therefore, there is a need to search
for alternate chondrogenic cell sources and culture methods to minimise the number of
chondrocytes needed.

4.3.2 Mesenchymal Stem cells
A promising cell source in the field of cartilage repair is the mesenchymal stem cells (MSC).
MSCs are adult stem cells that have the potential to differentiate into tissues including bone,
fat or cartilage [113]. They can be isolated from various human tissues, including bone marrow,
umbilical cord, and adipose tissue. MSCs hold great promise in the field of cartilage
regeneration due to their chondrogenic differentiation capability and their non-immunogenic
nature [114, 115]. This key characteristic of MSCs, where they express low to intermediate
levels of human leukocyte antigen (HLA) class I and are negative for cell surface expression
of HLA class II molecules, makes them suitable for allogeneic therapy [116]. Interestingly,
chondrocytes, adipocytes and osteocytes differentiated from human MSCs were also shown to
be non-immunogenic in nature [112, 116]. Furthermore, the initial cell numbers required to
culture and straightforward in vitro expansion protocols are an attractive cell source for tissue
engineering. These all indicated that MSCs could be used as off-shelf product for allogeneic
application for cartilage repair.
More recently, there are emerging studies suggesting the benefits of using co-cultures of
chondrocytes and MSCs in cartilage regeneration. Studies have shown that co-culturing not
only leads to increased chondrogenic gene expressions and ECM deposition [117-119], but
could also solve the problem of hypertrophy and calcification in MSCs due to extensive
chondrogenic induction [120-122]. A study by Meretoja et al. [120] also found that the trophic

effect of MSCs may increase the chondrogenic potentials of chondrocytes, thus reducing
problems associated with primary chondrocyte harvesting and expansion. The exact molecular
mechanism resulting in the stimulatory effect on the production of cartilage-like ECM when
both cell types are co-cultured are yet to be fully understood. But there are studies suggesting
that soluble factors such as transforming growth factor-β (TGF-β2), insulin-like growth factors
(IGF-1), and bone morphogenetic protein (BMP-2), secreted by chondrocytes provide the
initial chondrogenic signals [117, 123], while other studies demonstrated that cartilage specific
matrices produced by chondrocytes are the key in differentiation of MSCs [124, 125]. One
thing for certain is the synergistic effect between MSC and chondrocytes, where MSCs induce
chondrocyte proliferation and chondrocytes stimulate MSC chondrogenesis, thus eliminating
the need for constant stimulation of MSCs by growth factors into chondrocytes.
4.3.3 Chondroprogenitor
Chondroprogenitor cells or cartilage stem/progenitors cells in the perichondral layer of the
auricular cartilage may serve as an alternate source of cells for elastic cartilage reconstruction
[126]. Progenitor cells are very similar to stem cells and have the ability to differentiate into a
specific cell type. However, they are more specific than a stem cell and are only able to
differentiate into its target cell-type. These cartilage progenitor cells have been identified to
have the ability to differentiate into elastic cartilage, but also to regenerate both the
perichondrium and chondrium layers, which may be beneficial for long term stability of any
implant [126, 127].
The advantage of using autologous auricular progenitor cells as compared to harvesting
primary chondrocytes is that it is a minimally invasive procedure that can be obtained from a
thin fibrous layer of the auricle, even from microtia patients. From the perichondrial tissue,
they can be isolated, cultured and guided TGF-β2 and IGF-1 [128]. The chondrogenic potential
in these types of cells are also found to be age related with younger donors demonstrating five
times higher in glycosaminoglycan (GAG) synthesis and collagen type II formation than older
donors [113, 128]. In addition, they are highly proliferative and can therefore shorten the in
vitro culture period [129]. Reports of using perichondrial grafts with different biomaterials to
enhance chondrogenesis have also been investigated. Collagen sponge wrapped in
perichondrium implanted into rabbit models after 7 weeks showed accelerated cartilage
formation than materials containing perichondrium alone [130]. This was also the case when
ear perichondrium was wrapped around a piece of demineralised bone matrix and implanted

[131]. These results indicated that not only the cartilage progenitor cells could produce
collagenous components, but are also able to maintain a non-calcified phenotype in the
reconstructed cartilage. They represent a promising cell source for cartilage regeneration but
longer in vivo studies are required.

5. Conclusion
The best surgical treatment for microtia, either autologous, alloplastic or prosthetic for
auricular reconstruction is determined by various factors. These are mainly patient related
factors (age, medication, and allergies), pathology of the residual ear, existing scars, and
condition of surrounding tissue. The decision of whether the patient should undergo
reconstruction via the autologous or alloplastic option also depends on the surgeon's experience
and expertise. One of the limitations in traditional alloplastic frameworks is to accommodate
individual patient’s reconstructive needs. Autologous reconstruction was better in this aspect
in that there is no size or shape limitations as this can be modified during surgery, but comes
with various degrees of complications. The use of prosthetics are also reserved for special cases
and usually considered when the previous two options have failed.
The combination of tissue engineering and additive manufacturing represents a new era to
create custom-made tissue engineering solution to reconstructive surgery, which is heavily
reliant on donor grafts and synthetic biomaterials. Compared to other organs, the cartilage is
less complicated because of its avascular, aneural and alymphatic nature due to the dense ECM.
Nevertheless, the combination of biomaterials, cells and biofabrication techniques to mimic the
human ear still requires careful selection of appropriate structural, sacrificial, cell supporting
materials and cell source. The choice between chondrocytes, stem cells, chondroprogenitor
cells or co-culturing of cells, can all influence the final tissue morphology and composition as
it matures over time.

6. Current challenges and future trend
Cartilage tissue engineering through bioprinting provided an alternative to currently used
techniques that suffer from various limitations, but auricular cartilage regeneration is still at its
infancy [132]. Longer in vivo and in vitro evaluation and efficacy studies are required. In
addition, an ongoing aspect of bioprinting is stem cell harvesting and culturing for use in

bioinks. Without an economically viable, efficient and reproducible method, bioprinting for
cartilage regeneration cannot progress onto clinical trials. The use of pre-differentiated stem
cells still meant that it requires at least 4-6 weeks of culture in vitro and for autologous
procedures, the speed of cell processing is critical and requires more attention. Bioreactors may
provide a vital role in maturation during in vitro culture, as reports have shown that the use of
bioreactors speeds up the tissue maturation process and distribute nutrients uniformly across
the scaffold. This resulted in better deposition of ECM [133].
Although auricular reconstruction is an aesthetic practice that requires a customised approach,
the ongoing challenge is also in the performance and integration of the scaffold longer term.
Bioprinting has already simplified the solution to fabricate an exact replica of the contralateral
ear cartilage and the challenge now is to provide the required internal architecture or biological
cues to better mimic the native cartilage and allow integration/vascularisation [134]. Studies
now are leaning towards depositing multiple tissue types or materials into a single construct,
as well as using multiple fabrication techniques to produce the scaffold [135, 136]. The use of
chondrocytes alone cannot provide the sufficient cell numbers for a full size scaffold and more
focus is on the use of MSC or adipose stem cell (ADSC) as they offer larger number of cells
with high chondrogenic potential and readily accessible. Another challenge is to regenerate not
just the cartilage but the skin and earlobe, which consist of fat cells. Cartilage and fat tissue
induced simultaneously through co-culture has been shown possible by studies conducted by
Lee et al. [137] and can fully utilise the capability of biofabrication technology. In addition, as
the direction is heading towards better and more precise deposition of biological materials,
laser based bioprinting techniques such as laser induced forward transfer (LIFT) offer several
advantages over inkjet and extrusion based printing systems. The spot size resolution is close
to the inkjet resolution of 40-100 µm and the printing speed is faster than extrusion. Since this
method is nozzle-free, the viscosity (1-300 mPa/s) and cell density (1×108 cells/ml) achievable
by this technique are much higher than inkjet [138]. However, a viscous material also suggests
that cell distribution may not be uniform and the side effects of extended or intense laser
exposure on the cell are yet to be well understood [139]. Further studies into the complementary
use of different fabrication techniques, such as melt electro writing (MEW) [136, 140], inkjet,
laser and extrusion based printing systems may open new doors where the scaffold itself can
direct cell growth or maturation through internal architecture and variations in mechanical
properties.
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